Ann Hynes
Stock Analyst at Mizuho
(4.38)
# 401
Out of 4,734 analysts
230
Total ratings
63.03%
Success rate
12.39%
Average return
Main Sectors:
Stocks Rated by Ann Hynes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MD Pediatrix Medical Group | Maintains: Neutral | $13 → $15 | $14.00 | +7.14% | 11 | Nov 19, 2024 | |
| ELV Elevance Health | Maintains: Outperform | $585 → $505 | $389.22 | +29.75% | 3 | Nov 5, 2024 | |
| CAH Cardinal Health | Maintains: Neutral | $110 → $120 | $127.83 | -6.13% | 8 | Nov 4, 2024 | |
| BTSG BrightSpring Health Services | Maintains: Outperform | $17 → $20 | $20.89 | -4.26% | 1 | Nov 4, 2024 | |
| DGX Quest Diagnostics | Maintains: Outperform | $160 → $174 | $152.65 | +13.99% | 12 | Oct 24, 2024 | |
| CVS CVS Health | Maintains: Outperform | $73 → $66 | $53.15 | +24.18% | 9 | Oct 24, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Outperform | $28 | $22.30 | +25.56% | 1 | Aug 19, 2024 | |
| ARDT Ardent Health Partners | Initiates: Outperform | $20 | $14.21 | +40.75% | 1 | Aug 12, 2024 | |
| CRL Charles River Laboratories International | Initiates: Neutral | $235 | $169.81 | +38.39% | 1 | Jun 7, 2024 | |
| FTRE Fortrea Holdings | Initiates: Neutral | $27 | $18.70 | +44.39% | 1 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $435 | $347.52 | +25.17% | 1 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $84 → $70 | $44.37 | +57.76% | 9 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $118 → $130 | $134.43 | -3.30% | 14 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $93 → $95 | $95.79 | -0.82% | 8 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $346 | $205.07 | +68.72% | 13 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $370 → $385 | $288.59 | +33.41% | 10 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $200 | $188.78 | +5.94% | 15 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $242 → $268 | $1.98 | +13,435.35% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $450 → $505 | $586.08 | -13.83% | 19 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $550 → $400 | $284.67 | +40.51% | 7 | Jan 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $257 → $230 | $243.99 | -5.73% | 15 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $325 → $275 | $318.47 | -13.65% | 20 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $31 → $25 | $11.37 | +119.88% | 8 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $229 | $205.69 | +11.33% | 10 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $50 | $20.47 | +144.26% | 2 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $600 → $549 | $524.99 | +4.57% | 16 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $76 | $63.66 | +19.38% | 7 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $345 → $366 | $297.44 | +23.05% | 6 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $57 | $1.73 | +3,203.96% | 1 | Sep 21, 2017 |
Pediatrix Medical Group
Nov 19, 2024
Maintains: Neutral
Price Target: $13 → $15
Current: $14.00
Upside: +7.14%
Elevance Health
Nov 5, 2024
Maintains: Outperform
Price Target: $585 → $505
Current: $389.22
Upside: +29.75%
Cardinal Health
Nov 4, 2024
Maintains: Neutral
Price Target: $110 → $120
Current: $127.83
Upside: -6.13%
BrightSpring Health Services
Nov 4, 2024
Maintains: Outperform
Price Target: $17 → $20
Current: $20.89
Upside: -4.26%
Quest Diagnostics
Oct 24, 2024
Maintains: Outperform
Price Target: $160 → $174
Current: $152.65
Upside: +13.99%
CVS Health
Oct 24, 2024
Maintains: Outperform
Price Target: $73 → $66
Current: $53.15
Upside: +24.18%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Outperform
Price Target: $28
Current: $22.30
Upside: +25.56%
Ardent Health Partners
Aug 12, 2024
Initiates: Outperform
Price Target: $20
Current: $14.21
Upside: +40.75%
Charles River Laboratories International
Jun 7, 2024
Initiates: Neutral
Price Target: $235
Current: $169.81
Upside: +38.39%
Fortrea Holdings
May 28, 2024
Initiates: Neutral
Price Target: $27
Current: $18.70
Upside: +44.39%
May 28, 2024
Initiates: Buy
Price Target: $435
Current: $347.52
Upside: +25.17%
May 3, 2024
Maintains: Neutral
Price Target: $84 → $70
Current: $44.37
Upside: +57.76%
May 1, 2024
Reiterates: Buy
Price Target: $118 → $130
Current: $134.43
Upside: -3.30%
Apr 25, 2024
Maintains: Buy
Price Target: $93 → $95
Current: $95.79
Upside: -0.82%
Apr 4, 2024
Reiterates: Buy
Price Target: $346
Current: $205.07
Upside: +68.72%
Mar 8, 2024
Maintains: Buy
Price Target: $370 → $385
Current: $288.59
Upside: +33.41%
Mar 6, 2024
Maintains: Buy
Price Target: $175 → $200
Current: $188.78
Upside: +5.94%
Feb 23, 2024
Maintains: Buy
Price Target: $242 → $268
Current: $1.98
Upside: +13,435.35%
Feb 9, 2024
Maintains: Neutral
Price Target: $450 → $505
Current: $586.08
Upside: -13.83%
Jan 26, 2024
Maintains: Buy
Price Target: $550 → $400
Current: $284.67
Upside: +40.51%
Oct 31, 2023
Maintains: Buy
Price Target: $257 → $230
Current: $243.99
Upside: -5.73%
Oct 25, 2023
Maintains: Buy
Price Target: $325 → $275
Current: $318.47
Upside: -13.65%
Oct 10, 2023
Maintains: Neutral
Price Target: $31 → $25
Current: $11.37
Upside: +119.88%
Oct 10, 2023
Maintains: Buy
Price Target: $250 → $229
Current: $205.69
Upside: +11.33%
Jul 11, 2023
Maintains: Buy
Price Target: $48 → $50
Current: $20.47
Upside: +144.26%
Jul 11, 2023
Maintains: Buy
Price Target: $600 → $549
Current: $524.99
Upside: +4.57%
Jul 11, 2023
Maintains: Neutral
Price Target: $80 → $76
Current: $63.66
Upside: +19.38%
Jul 29, 2022
Maintains: Buy
Price Target: $345 → $366
Current: $297.44
Upside: +23.05%
Sep 21, 2017
Initiates: Neutral
Price Target: $57
Current: $1.73
Upside: +3,203.96%